journal
https://read.qxmd.com/read/38889693/randomization-bias-multi-morbidity-and-the-composite-clinical-score
#1
EDITORIAL
Ralph I Horwitz, James B Baker, Arnab Ghatak, Mark R Cullen
No abstract text is available yet for this article.
June 18, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38880086/the-role-of-neurosciences-in-clinical-interviewing
#2
LETTER
Stefano Pallanti
No abstract text is available yet for this article.
June 14, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38838654/appreciating-the-limits-and-opportunities-of-meta-analyses-to-understand-complex-psychological-trajectories-reply-to-da-silveira-et-al
#3
LETTER
Amelia J Scott, Ashleigh B Correa, Madelyne A Bisby, Blake F Dear
No abstract text is available yet for this article.
June 5, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38830341/the-person-centred-clinical-interview
#4
EDITORIAL
Tom Sensky
No abstract text is available yet for this article.
June 3, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38772349/wfp-news-section
#5
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
May 21, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38768564/treating-posttraumatic-stress-disorder-the-complexities-of-the-clinical-realm
#6
EDITORIAL
Ulrich Schnyder
No abstract text is available yet for this article.
May 20, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38754399/oxytocin-augmented-modular-based-group-intervention-for-loneliness-a-proof-of-concept-randomized-controlled-trial
#7
JOURNAL ARTICLE
Ruben Berger, Rene Hurlemann, Simone Shamay-Tsoory, Alisa Kanterman, Maura Brauser, Jessica Gorni, Maike Luhmann, Elisabeth Schramm, Johannes Schultz, Alexandra Philipsen, Jana Lieberz, Dirk Scheele
INTRODUCTION: Loneliness poses a significant health problem and existing psychological interventions have shown only limited positive effects on loneliness. Based on preliminary evidence for impaired oxytocin signaling in trait-like loneliness, the current proof-of-concept study used a randomized, double-blind, placebo-controlled design to probe intranasal oxytocin (OT) as an adjunct to a short-term modular-based group intervention for individuals suffering from high trait-like loneliness (HL, UCLA Loneliness Scale ≥55)...
May 16, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38688243/efficacy-of-an-internet-and-mobile-based-intervention-for-subclinical-anxiety-and-depression-icare-prevent-with-two-guidance-formats-results-from-a-three-armed-randomized-controlled-trial
#8
JOURNAL ARTICLE
Anna-Carlotta Zarski, Kiona K Weisel, Thomas Berger, Tobias Krieger, Michael P Schaub, Matthias Berking, Dennis Görlich, Corinna Jacobi, David D Ebert
INTRODUCTION: Limited research exists on intervention efficacy for comorbid subclinical anxiety and depressive disorders, despite their common co-occurrence. Internet- and mobile-based interventions (IMIs) are promising to reach individuals facing subclinical symptoms. OBJECTIVE: This study aimed to evaluate the efficacy of a transdiagnostic and self-tailored IMI in reducing subclinical anxiety and depressive symptom severity with either individualized (IG-IMI) or automated (AG-IMI) guidance compared to a waitlist control group with care-as-usual access (WLC)...
April 30, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38688242/enhanced-skills-training-in-affective-and-interpersonal-regulation-versus-treatment-as-usual-for-icd-11-complex-ptsd-a-pilot-randomised-controlled-trial-the-restore-trial
#9
JOURNAL ARTICLE
Thanos Karatzias, Mark Shevlin, Marylène Cloitre, Walter Busuttil, Katherine Graham, Laura Hendrikx, Philip Hyland, Natasha Biscoe, Dominic Murphy
INTRODUCTION: Complex PTSD (CPTSD) is a relatively new condition in ICD-11. This pilot randomised controlled trial aimed to compare a four-module intervention developed to target all symptoms of ICD-11 CPTSD, namely Enhanced Skills in Affective and Interpersonal Regulation (ESTAIR) with treatment as usual (TAU). The purpose of the study was to assess feasibility, safety, acceptability, and preliminary outcomes at the end of treatment and 3-month follow-up. METHODS: A total of N = 56 eligible veterans with CPTSD were randomised to either ESTAIR (n = 28) or TAU (n = 28)...
April 30, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38663360/the-checklist-psychiatrist
#10
EDITORIAL
Richard Balon
No abstract text is available yet for this article.
April 25, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38636469/clinical-use-of-staging-in-psychiatry
#11
EDITORIAL
Giovanni A Fava
No abstract text is available yet for this article.
April 18, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38615662/long-term-effectiveness-of-cognitive-behavioral-therapy-in-routine-outpatient-care-for-youth-with-anxiety-disorders
#12
JOURNAL ARTICLE
Karen Krause, Xiao Chi Zhang, Silvia Schneider
INTRODUCTION: This study examined the long-term effectiveness of cognitive behavioral therapy (CBT) (≥ 2 years after the end of therapy) in the routine care of youth (mean 11.95 years; SD = 3.04 years) with primary anxiety disorder (AD). METHODS: Two hundred and ten children with any AD as a primary diagnosis and with any comorbidity were included in the "Kids Beating Anxiety (KibA)" clinical trial and received evidence-based CBT. Diagnoses, severity of diagnoses, and further dimensional outcome variables of symptoms and functioning were assessed before (baseline), after the last treatment session (POST), and at two follow-up (FU) assessments in the child and caregiver report: 6 months (6MONTHS-FU) and >2 years (mean 4...
April 12, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38615655/the-endeavor-to-predict-depression-and-anxiety-trajectories-in-the-context-of-chronic-diseases-remains-a-formidable-challenge
#13
LETTER
Pedro Lucas Santana da Silveira, Guilherme Nobre Nogueira, Marisa Bezerra de Araújo, Fabio Gomes de Matos E Souza, Luísa Weber Bisol
No abstract text is available yet for this article.
April 12, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38588654/indicated-stress-prevention-addressing-adolescents-with-high-stress-levels-based-on-principles-of-acceptance-and-commitment-therapy-a-randomized-controlled-trial
#14
JOURNAL ARTICLE
Franziska Binder, Julian Koenig, Franz Resch, Michael Kaess
INTRODUCTION: Stress affects many adolescents and is associated with physical and mental health symptoms that can have a negative impact on normative development. However, there are very few evidence-based, specific treatment approaches. The aim of the study was to investigate an eight-session group intervention using components of Acceptance and Commitment Therapy (ACT) enriched with elements of CBT (psychoeducation, problem solving) and art therapy, compared to a waitlist control (WLC) group, regarding its efficacy in reducing stress and associated symptoms...
April 8, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38493771/restoring-and-preserving-the-clinical-interview
#15
EDITORIAL
Kurt Kroenke
No abstract text is available yet for this article.
March 15, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38432207/icpm-news-section
#16
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
March 1, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38417415/acceptance-and-commitment-therapy-combined-with-bedtime-restriction-versus-cognitive-behavioral-therapy-for-insomnia-a-randomized-controlled-pilot-trial
#17
JOURNAL ARTICLE
Elisabeth Hertenstein, Ersilia Trinca, Carlotta L Schneider, Kristoffer D Fehér, Anna F Johann, Christoph Nissen
INTRODUCTION: Cognitive behavioral therapy for insomnia (CBT-I) is the current first-line treatment for insomnia. However, rates of nonresponse and nonremission are high and effects on quality of life are only small to moderate, indicating a need for novel treatment developments. We propose that Acceptance and Commitment Therapy (ACT) addresses core pathophysiological pathways of insomnia. ACT therefore has the potential to improve treatment efficacy when combined with bedtime restriction, the most effective component of CBT-I...
February 28, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38286128/psychological-treatment-of-comorbid-insomnia-and-depression-a-double-blind-randomized-placebo-controlled-trial
#18
JOURNAL ARTICLE
Kerstin Blom, Erik Forsell, Monica Hellberg, Cecilia Svanborg, Susanna Jernelöv, Viktor Kaldo
INTRODUCTION: Insomnia and depression are highly prevalent disorders and commonly occur together. Cognitive behavioral therapy for insomnia, CBT-I, has been shown to be effective in treating insomnia and also comorbid depression. However, it is unclear whether effects of CBT-I on depression are specific or nonspecific. Also, depressive symptoms often remain too high after CBT-I, indicating a need for improved treatments. The objective was to determine whether combining CBT-I with CBT for depression, without increasing treatment length, reduces both insomnia and depression more than CBT for depression with a placebo insomnia intervention...
January 29, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38272009/neuropsychological-assessments-of-cognitive-impairment-in-major-depressive-disorder-a-systematic-review-and-meta-analysis-with-meta-regression
#19
Taeho Greg Rhee, Sung Ryul Shim, Kevin J Manning, Howard A Tennen, Tyler S Kaster, Giacomo d'Andrea, Brent P Forester, Andrew A Nierenberg, Roger S McIntyre, David C Steffens
INTRODUCTION: Cognitive dysfunction or deficits are common in patients with major depressive disorder (MDD). The current study systematically reviews and meta-analyzes multiple domains of cognitive impairment in patients with MDD. METHODS: PubMed/MEDLINE, PsycINFO, Cochrane Library, Embase, Web of Science, and Google Scholar were searched from inception through May 17, 2023, with no language limits. Studies with the following inclusion criteria were included: (1) patients with a diagnosis of MDD using standardized diagnostic criteria; (2) healthy controls (i...
January 25, 2024: Psychotherapy and Psychosomatics
https://read.qxmd.com/read/38272007/one-day-peer-delivered-cognitive-behavioral-therapy-based-workshops-for-postpartum-depression-a-randomized-controlled-trial
#20
JOURNAL ARTICLE
Zoryana Babiy, Haley Layton, Calan D Savoy, Feng Xie, June S L Brown, Peter J Bieling, David L Streiner, Mark A Ferro, Ryan J Van Lieshout
INTRODUCTION: Myriad treatment barriers prevent birthing parents with postpartum depression (PPD) from receiving timely treatment. We aimed to determine whether a peer-delivered online 1-day cognitive behavioral therapy (CBT)-based workshop added to treatment as usual (TAU) improves PPD and its comorbidities and is more cost-effective than TAU alone. METHODS: This parallel-group, randomized controlled trial took place in Ontario, Canada (June 7, 2021, to February 18, 2022)...
January 25, 2024: Psychotherapy and Psychosomatics
journal
journal
21167
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.